Since the role of NSMase in the therapeutic benefits of probiotics has not been previously reported and because a large number of bacteria produce NSMase [24] and probiotics can induce apoptosis [25], we hypothesised that the probiotic strains used in the management of IBD might exert an anti-inflammatory effect by inducing immune cell death. The gene discussed is SMPD2; the disease is inflammatory bowel disease.